ERC Starting Grant · 2021
Synthetic Circular RNA therapeutics for prevention of sepsis-associated organ failure
Reversing organ failure, a leading cause of death in sepsis, requires specific modulation of biological pathways in endothelial cells, which is currently not possible with the existing drugs available. Employing RNA-based drugs to control protein expression could offer a novel therapeutic strategy in the fight against sepsis. Circular RNAs (circRNAs) are a new class of non-coding RNAs with a unique closed-loop structure that could help address the current limitations of the RNA drugs in the disease context and open new therapeutic avenues. Therapeutic delivery of engineered synthetic circRNAs can allow taking full advantage of their unique features and functions, including increased…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.
← All labs at National University of Ireland - University College Cork